Effects of TNF antagonists on immune and neuroendocrine system
In the article, the literature on the effects of TNFa-antagonists (etanercept, infliximab and adalimumab) on the immune system is reviewed. These biologic agents are employed in chronic inflammatory diseases such as rheumatoid arthritis, seronegative spondyloarthritides, as well as psoriasis and Cro...
Main Authors: | M. Cutolo, G. Valesini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-09-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/236 |
Similar Items
-
Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011-06-01) -
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
by: Ilaria Sauzullo, et al.
Published: (2010-06-01) -
Are there any positive effects of TNF-alpha blockers on bone metabolism?
by: A. Sulli, et al.
Published: (2011-09-01) -
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
by: Dendrou, C, et al.
Published: (2013) -
Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis
by: Julien Stievenart, et al.
Published: (2021-06-01)